0001683168-22-002002.txt : 20220328
0001683168-22-002002.hdr.sgml : 20220328
20220328171450
ACCESSION NUMBER: 0001683168-22-002002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220324
FILED AS OF DATE: 20220328
DATE AS OF CHANGE: 20220328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PARSLOW JAMES F
CENTRAL INDEX KEY: 0001285943
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37937
FILM NUMBER: 22776356
MAIL ADDRESS:
STREET 1: C/O XENETIC BIOSCIENCES, INC.
STREET 2: 99 HAYDEN AVENUE, SUITE 230
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenetic Biosciences, Inc.
CENTRAL INDEX KEY: 0001534525
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452952962
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 SPEEN STREET, SUITE 102
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
BUSINESS PHONE: 781-778-7720
MAIL ADDRESS:
STREET 1: 40 SPEEN STREET, SUITE 102
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
FORMER COMPANY:
FORMER CONFORMED NAME: General Sales & Leasing, Inc.
DATE OF NAME CHANGE: 20130227
FORMER COMPANY:
FORMER CONFORMED NAME: GENERAL AIRCRAFT INC.
DATE OF NAME CHANGE: 20111108
4
1
ownership.xml
X0306
4
2022-03-24
0
0001534525
Xenetic Biosciences, Inc.
XBIO
0001285943
PARSLOW JAMES F
40 SPEEN STREET, SUITE 102
FRAMINGHAM
MA
01701
0
1
0
0
Chief Financial Officer
Stock Options
1.12
2022-03-24
4
A
0
50000
0
A
2032-03-24
Common Stock
50000
50000
D
The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 24, 2022; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 24, 2023 and ending on March 24, 2025.
/s/ James Parslow
2022-03-28